PeptiSystems expands its presence in India with new customer collaborations

Uppsala, Sweden – 30 October 2025

PeptiSystems is continuing to grow its international footprint with new customer relationships in India. Two leading pharmaceutical organizations—Neuland Laboratories and Laurus Labs—have recently joined PeptiSystems’ expanding customer network in the region.

Neuland Laboratories, a global Contract Development and Manufacturing Organization (CDMO), provides customized small-molecule and peptide development services to pharmaceutical and biotech companies worldwide.

Laurus Labs, a research-driven pharmaceutical manufacturing organization, has equipped its facility with two PeptiPilots and one OligoNavigator, marking an important milestone as PeptiSystems’ first customer in India.

“These collaborations show how leading life science organizations are embracing next-generation manufacturing to advance peptide and oligonucleotide therapeutics,” says Karin Granath, CEO of PeptiSystems. “India’s life science community is exceptionally dynamic, and we’re proud to support our customers as they continue to drive innovation in this field.”

The growing interest from India highlights PeptiSystems’ international expansion and the company’s role in enabling more efficient, flexible, and sustainable drug development worldwide. With a strong customer base in Europe, North America, and now a growing presence in Asia, PeptiSystems continues to strengthen its position as a trusted partner for peptide and oligonucleotide manufacturing.